Developing new immunomodulators for patients with auto-immune diseases

Step Pharma is a biotechnology company discovering and developing proprietary small molecule therapeutics for the treatment of auto-immune diseases. Step’s lead program is selective modulators against specific immune cell populations which are the main drivers of auto-immune diseases.


Step Pharma Completes €14.5 million Series A Financing with Additional New Investor

Paris, France, 21 November 2017 – Step Pharma today announced the closing of a Series…

Read more